These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6282216)

  • 21. The safety and pharmacokinetics of cefotaxime in the treatment of neonates.
    de Louvois J; Mulhall A; Hurley R
    Pediatr Pharmacol (New York); 1982; 2(4):275-84. PubMed ID: 6099886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of dopamine in critically ill newborn infants.
    Padbury JF; Agata Y; Baylen BG; Ludlow JK; Polk DH; Habib DM; Martinez AM
    J Pediatr; 1990 Sep; 117(3):472-6. PubMed ID: 2391608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of cefotaxime in the domestic cat.
    McElroy D; Ravis WR; Clark CH
    Am J Vet Res; 1986 Jan; 47(1):86-8. PubMed ID: 3946912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
    Standiford HC; Drusano GL; McNamee WB; Tatem B; Ryan PA; Schimpff SC
    Rev Infect Dis; 1982; 4 Suppl():S585-94. PubMed ID: 6296967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefotaxime in the postpartum patient.
    Gonik B; Cotton DB; Feldman S; Cleary TG; Pickering LK
    Am J Perinatol; 1985 Apr; 2(2):114-7. PubMed ID: 4096751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of cefotaxime.
    Fu KP; Aswapokee P; Ho I; Matthijssen C; Neu HC
    Antimicrob Agents Chemother; 1979 Nov; 16(5):592-7. PubMed ID: 526000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of ceftriaxone in neonates and infants with meningitis.
    Martin E; Koup JR; Paravicini U; Stoeckel K
    J Pediatr; 1984 Sep; 105(3):475-81. PubMed ID: 6088747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of gestational age and birth weight on tobramycin kinetics in newborn infants.
    Nahata MC; Powell DA; Durrell DE; Miller MC; Glazer JP
    J Antimicrob Chemother; 1984 Jul; 14(1):59-65. PubMed ID: 6480541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and pharmacokinetic evaluation of cefotiam in neonates and young infants].
    Fujita K; Sakata H; Tanaka M; Kaeriyama M; Yoshioka H; Takimoto M; Takahashi Y
    Jpn J Antibiot; 1986 Sep; 39(9):2395-8. PubMed ID: 3467082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of cefotaxime in the dog.
    Guerrini VH; English PB; Filippich LJ; Schneider J; Bourne DW
    Vet Rec; 1986 Jul; 119(4):81-3. PubMed ID: 3750783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kinetics of multiple-dose amikacin in the newborn infant].
    Olivesi A; Camboulives J; Charrel C; Unal D
    Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
    Trang JM; Jacobs RF; Kearns GL; Brown AL; Wells TG; Underwood FL; Kluza RB
    Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.
    Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liver.
    Höffken G; Lode H; Koeppe P; Ruhnke M; Borner K
    Chemotherapy; 1984; 30(1):7-17. PubMed ID: 6319092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetic and clinical studies of cefotiam in neonates and premature infants].
    Toyonaga Y; Sugita M; Kurosu Y; Hori M
    Jpn J Antibiot; 1986 Sep; 39(9):2421-35. PubMed ID: 3467084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of cefotaxime after a single intravenous dose in patients with impaired renal function.
    Moukhtar I; Nawishy S; Sabbour M
    Chemioterapia; 1987 Feb; 6(1):38-40. PubMed ID: 3829135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetic and clinical studies of cefotiam in mature neonates].
    Nishimura T; Tabuki K; Takashima T
    Jpn J Antibiot; 1986 Sep; 39(9):2450-7. PubMed ID: 3467086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.
    Lüthy R; Blaser J; Bonetti A; Simmen H; Wise R; Siegenthaler W
    Antimicrob Agents Chemother; 1981 Nov; 20(5):567-75. PubMed ID: 6275776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of carbenicillin in neonates of normal and low birth weight.
    Morehead CD; Shelton S; Kusmiesz H; Nelson JD
    Antimicrob Agents Chemother; 1972 Oct; 2(4):267-71. PubMed ID: 4670498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.